Stardust Power Closes Business Combination and Set to Begin Trading on Nasdaq
Stardust Power Closes Business Combination Agreement with Global Partner Acquisition Corp II Stardust Power set to begin trading on Nasdaq […]
Casella Waste Systems, Inc. to Host Conference Call on its Second Quarter 2024 Results and to Present at an Upcoming Investor Event
RUTLAND, Vt., July 08, 2024 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and […]
Final Call to Action: Vote Your Pineapple Shares
MINNETONKA, Minn., July 08, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY) (“Pineapple” or the “Company”), a leading provider […]
Armada Hoffler to Report Second Quarter Earnings on August 7th
VIRGINIA BEACH, Va., July 08, 2024 (GLOBE NEWSWIRE) — Armada Hoffler (NYSE: AHH) will report its earnings for the quarter […]
Axalta Appoints Chris Evans Vice President, Global Strategy, and Colleen Lubic Vice President, Investor Relations
PHILADELPHIA, July 08, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems Ltd. (NYSE: AXTA), a leading global coatings company, today announced […]
ESCO Announces Acquisition of Navy Supplier
St. Louis, July 08, 2024 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) today announced that it has agreed to […]
Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility
WARREN, N.J., July 08, 2024 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, founding CEO of Tevogen Bio (“Tevogen”) (Nasdaq: TVGN), […]
Rigetti to Present Keynote at SEMICON West 2024
BERKLEY, Calif., July 08, 2024 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in […]
ThredUp to Report Second Quarter 2024 Financial Results on August 5, 2024
OAKLAND, Calif., July 08, 2024 (GLOBE NEWSWIRE) — ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms […]
Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
